The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification of antigen-receptor gene sequences-Reference-Cited by-同舟云学术

The clinical significance of residual disease in childhood acute lymphoblastic leukemia as detected by polymerase chain reaction amplification of antigen-receptor gene sequences

Published:1996-01 Issue:3-4 Volume:20 Page:181-197
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Roberts W. Mark,Estrov Zeev,Kitchingman Geoffrey R.,Zipf Theodore F.

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

http://www.tandfonline.com/doi/pdf/10.3109/10428199609051607

Reference50 articles.

1. Detection of residual disease in acute leukemia using immunological markers

2. Biology and clinical significance of cytogenetic abnormalities in childhood acute lymphoblastic leukemia

3. Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders

4. A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Flow cytometric detection of minimal residual disease in acute lymphoblastic leukemia;LEUKEMIA LYMPHOMA;2003

2. Risk classification at the time of diagnosis differentially affects the level of residual disease in children with B-precursor acute lymphoblastic leukemia after completion of therapy;Leukemia Research;2003-08

3. Flow Cytometric Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia;Leukemia & Lymphoma;2003-01

4. Practical application of minimal residual disease assessment in childhood acute lymphoblastic leukaemia;British Journal of Haematology;2001-02

5. Immunological Detection of Minimal Residual Disease in Acute Lymphoblastic Leukemia;Oncology Research and Treatment;2001